Literature DB >> 26896063

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A case report.

A Llorca-Cardeñosa1, J Català-Mora2, A García-Cazorla3, S Meavilla4, E Castejón-Ponce4.   

Abstract

CLINICAL CASE: A five-year-old patient, with a diagnosis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, was referred for an ophthalmological examination. He had a history of acute metabolic crises precipitated by intercurrent infections,as well as rhabdomyolysis. The fundoscopic examination revealed a peripapillary chorioretinal atrophy and a diffuse granular appearance of the macular retinal pigment epithelium. Best corrected visual acuity was 6/6 in both eyes, and he had a normal electroretinography test. DISCUSSION: We perform a review of the literature and recent findings in relation to this disease through the description of a clinical case in order to improve the knowledge of this uncommon disorder.
Copyright © 2016 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Chorioretinopathy; Coriorretinopatía; Déficit de 3-hidroxiacil-CoA deshidrogenasa de cadena larga; Fatty acid; Gen HADHA; HADHA gene; Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency; Neural retina; Retina neural; Ácidos grasos

Mesh:

Substances:

Year:  2016        PMID: 26896063     DOI: 10.1016/j.oftal.2016.01.006

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  2 in total

1.  Follow-up and multimodal imaging in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  Glenda Espinosa-Barberi; Sara Miranda Fernández; Michel Ernesto Valdés Martín; María Ángeles Betancor Perdomo; Carmen Julissa Aguilar Rosales
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

2.  Expanding the genotype-phenotype correlation of childhood sensory polyneuropathy of genetic origin.

Authors:  Samya Chakravorty; Rachel Logan; Molly J Elson; Rebecca R Luke; Sumit Verma
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.